Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Effects and Response of LY2605541 in Patients With Type 1 Diabetes Mellitus (BIDO)
Evaluation of the Effects of LY2605541 on Respiratory Quotient During Sleep and Response to Hyperinsulinemia Compared With That of Insulin Glargine in Patients With Type 1 Diabetes Mellitus (BIDO)
Status: Enrolling
Updated:  1/12/2017
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Effects and Response of LY2605541 in Patients With Type 1 Diabetes Mellitus (BIDO)
Evaluation of the Effects of LY2605541 on Respiratory Quotient During Sleep and Response to Hyperinsulinemia Compared With That of Insulin Glargine in Patients With Type 1 Diabetes Mellitus (BIDO)
Status: Enrolling
Updated: 1/12/2017
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Click here to add this to my saved trials
Alliance to Control Diabetes
Alliance to Control Diabetes
Status: Enrolling
Updated:  1/12/2017
San Diego State University Research Foundation
mi
from
Calexico, CA
Alliance to Control Diabetes
Alliance to Control Diabetes
Status: Enrolling
Updated: 1/12/2017
San Diego State University Research Foundation
mi
from
Calexico, CA
Click here to add this to my saved trials
Alliance to Control Diabetes
Alliance to Control Diabetes
Status: Enrolling
Updated:  1/12/2017
San Diego State University Research Foundation
mi
from
San Diego, CA
Alliance to Control Diabetes
Alliance to Control Diabetes
Status: Enrolling
Updated: 1/12/2017
San Diego State University Research Foundation
mi
from
San Diego, CA
Click here to add this to my saved trials
Closed-Loop Control in Young Children 5-8 Years Old Using DiAs Platform
Closed-Loop Control in Young Children 5-8 Years Old Using DiAs Platform
Status: Enrolling
Updated:  1/12/2017
University of Virginia, Center for Diabetes Technology
mi
from
Charlottesville, VA
Closed-Loop Control in Young Children 5-8 Years Old Using DiAs Platform
Closed-Loop Control in Young Children 5-8 Years Old Using DiAs Platform
Status: Enrolling
Updated: 1/12/2017
University of Virginia, Center for Diabetes Technology
mi
from
Charlottesville, VA
Click here to add this to my saved trials
GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus
GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  1/12/2017
Novo Nordisk Investigational Site
mi
from
Princeton, NJ
GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus
GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/12/2017
Novo Nordisk Investigational Site
mi
from
Princeton, NJ
Click here to add this to my saved trials
GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus
GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  1/12/2017
Novo Nordisk Investigational Site
mi
from
Mississauga,
GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus
GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/12/2017
Novo Nordisk Investigational Site
mi
from
Mississauga,
Click here to add this to my saved trials
A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and Metoprolol
A Two-cohort, Open-label, Fixed-sequence, Two-period, Two-treatment Pharmacokinetic Interaction Study of Repeated Oral Doses of Sotagliflozin on a Single Dose Cocktail of Metoprolol and Midazolam Used as Probe Substrates for CYP2D6 and CYP3A Activities, Respectively, in Healthy Subjects
Status: Enrolling
Updated:  1/17/2017
Clinical Research Facility
mi
from
Knoxville, TN
A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and Metoprolol
A Two-cohort, Open-label, Fixed-sequence, Two-period, Two-treatment Pharmacokinetic Interaction Study of Repeated Oral Doses of Sotagliflozin on a Single Dose Cocktail of Metoprolol and Midazolam Used as Probe Substrates for CYP2D6 and CYP3A Activities, Respectively, in Healthy Subjects
Status: Enrolling
Updated: 1/17/2017
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects
A Single-Blind, Randomized, Placebo Controlled, Ascending Single and Repeat Dose Study With Once Daily Dosing to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK376501 and to Evaluate Food Effects and the Relative Bioavailability of a Tablet Formulation Compared to the Powder for Reconstitution Formulation in Healthy Overweight and Obese Subjects (DIX109177)
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Evansville, IN
A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects
A Single-Blind, Randomized, Placebo Controlled, Ascending Single and Repeat Dose Study With Once Daily Dosing to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK376501 and to Evaluate Food Effects and the Relative Bioavailability of a Tablet Formulation Compared to the Powder for Reconstitution Formulation in Healthy Overweight and Obese Subjects (DIX109177)
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Evansville, IN
Click here to add this to my saved trials
Comparison of Glycemic Control Achieved With 2 Different Needles
Comparison of Glycemic Control Achieved With a 31 Gauge x 6 mm NovoFine® Needle vs. a BD 29 Gauge x 12.7 mm Ultra-Fine® Needle in Subjects With Diabetes Mellitus and a BMI Exceeding 30 kg/m2: An Open Label, Randomized, Two-Period Crossover Study
Status: Enrolling
Updated:  1/18/2017
Novo Nordisk Investigational Site
mi
from
Walnut Creek, CA
Comparison of Glycemic Control Achieved With 2 Different Needles
Comparison of Glycemic Control Achieved With a 31 Gauge x 6 mm NovoFine® Needle vs. a BD 29 Gauge x 12.7 mm Ultra-Fine® Needle in Subjects With Diabetes Mellitus and a BMI Exceeding 30 kg/m2: An Open Label, Randomized, Two-Period Crossover Study
Status: Enrolling
Updated: 1/18/2017
Novo Nordisk Investigational Site
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Comparison of Glycemic Control Achieved With 2 Different Needles
Comparison of Glycemic Control Achieved With a 31 Gauge x 6 mm NovoFine® Needle vs. a BD 29 Gauge x 12.7 mm Ultra-Fine® Needle in Subjects With Diabetes Mellitus and a BMI Exceeding 30 kg/m2: An Open Label, Randomized, Two-Period Crossover Study
Status: Enrolling
Updated:  1/18/2017
Novo Nordisk Investigational Site
mi
from
Berlin, NJ
Comparison of Glycemic Control Achieved With 2 Different Needles
Comparison of Glycemic Control Achieved With a 31 Gauge x 6 mm NovoFine® Needle vs. a BD 29 Gauge x 12.7 mm Ultra-Fine® Needle in Subjects With Diabetes Mellitus and a BMI Exceeding 30 kg/m2: An Open Label, Randomized, Two-Period Crossover Study
Status: Enrolling
Updated: 1/18/2017
Novo Nordisk Investigational Site
mi
from
Berlin, NJ
Click here to add this to my saved trials
Comparison of Glycemic Control Achieved With 2 Different Needles
Comparison of Glycemic Control Achieved With a 31 Gauge x 6 mm NovoFine® Needle vs. a BD 29 Gauge x 12.7 mm Ultra-Fine® Needle in Subjects With Diabetes Mellitus and a BMI Exceeding 30 kg/m2: An Open Label, Randomized, Two-Period Crossover Study
Status: Enrolling
Updated:  1/18/2017
Novo Nordisk Investigational Site
mi
from
Lawrenceville, NJ
Comparison of Glycemic Control Achieved With 2 Different Needles
Comparison of Glycemic Control Achieved With a 31 Gauge x 6 mm NovoFine® Needle vs. a BD 29 Gauge x 12.7 mm Ultra-Fine® Needle in Subjects With Diabetes Mellitus and a BMI Exceeding 30 kg/m2: An Open Label, Randomized, Two-Period Crossover Study
Status: Enrolling
Updated: 1/18/2017
Novo Nordisk Investigational Site
mi
from
Lawrenceville, NJ
Click here to add this to my saved trials
Comparison of Glycemic Control Achieved With 2 Different Needles
Comparison of Glycemic Control Achieved With a 31 Gauge x 6 mm NovoFine® Needle vs. a BD 29 Gauge x 12.7 mm Ultra-Fine® Needle in Subjects With Diabetes Mellitus and a BMI Exceeding 30 kg/m2: An Open Label, Randomized, Two-Period Crossover Study
Status: Enrolling
Updated:  1/18/2017
Novo Nordisk Investigational Site
mi
from
Kettering, OH
Comparison of Glycemic Control Achieved With 2 Different Needles
Comparison of Glycemic Control Achieved With a 31 Gauge x 6 mm NovoFine® Needle vs. a BD 29 Gauge x 12.7 mm Ultra-Fine® Needle in Subjects With Diabetes Mellitus and a BMI Exceeding 30 kg/m2: An Open Label, Randomized, Two-Period Crossover Study
Status: Enrolling
Updated: 1/18/2017
Novo Nordisk Investigational Site
mi
from
Kettering, OH
Click here to add this to my saved trials
Comparison of Glycemic Control Achieved With 2 Different Needles
Comparison of Glycemic Control Achieved With a 31 Gauge x 6 mm NovoFine® Needle vs. a BD 29 Gauge x 12.7 mm Ultra-Fine® Needle in Subjects With Diabetes Mellitus and a BMI Exceeding 30 kg/m2: An Open Label, Randomized, Two-Period Crossover Study
Status: Enrolling
Updated:  1/18/2017
Novo Nordisk Investigational Site
mi
from
San Antonio, TX
Comparison of Glycemic Control Achieved With 2 Different Needles
Comparison of Glycemic Control Achieved With a 31 Gauge x 6 mm NovoFine® Needle vs. a BD 29 Gauge x 12.7 mm Ultra-Fine® Needle in Subjects With Diabetes Mellitus and a BMI Exceeding 30 kg/m2: An Open Label, Randomized, Two-Period Crossover Study
Status: Enrolling
Updated: 1/18/2017
Novo Nordisk Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Diabetes Attitudes Wishes and Needs
Diabetes Attitudes Wishes and Needs (DAWN) 2 Study: A Multinational, Multi-stakeholder Survey Study of Psychosocial Issues in Diabetes and Patient-centred Diabetes Care
Status: Enrolling
Updated:  1/18/2017
Novo Nordisk Investigational Site
mi
from
Princeton, NJ
Diabetes Attitudes Wishes and Needs
Diabetes Attitudes Wishes and Needs (DAWN) 2 Study: A Multinational, Multi-stakeholder Survey Study of Psychosocial Issues in Diabetes and Patient-centred Diabetes Care
Status: Enrolling
Updated: 1/18/2017
Novo Nordisk Investigational Site
mi
from
Princeton, NJ
Click here to add this to my saved trials
Diabetes Attitudes Wishes and Needs
Diabetes Attitudes Wishes and Needs (DAWN) 2 Study: A Multinational, Multi-stakeholder Survey Study of Psychosocial Issues in Diabetes and Patient-centred Diabetes Care
Status: Enrolling
Updated:  1/18/2017
Novo Nordisk Investigational Site
mi
from
Algiers,
Diabetes Attitudes Wishes and Needs
Diabetes Attitudes Wishes and Needs (DAWN) 2 Study: A Multinational, Multi-stakeholder Survey Study of Psychosocial Issues in Diabetes and Patient-centred Diabetes Care
Status: Enrolling
Updated: 1/18/2017
Novo Nordisk Investigational Site
mi
from
Algiers,
Click here to add this to my saved trials
Accuracy Characterization Study
Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System Compared to Venous and Capillary Glucose
Status: Enrolling
Updated:  1/23/2017
Diablo Clinical Research Inc
mi
from
Walnut creek, CA
Accuracy Characterization Study
Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System Compared to Venous and Capillary Glucose
Status: Enrolling
Updated: 1/23/2017
Diablo Clinical Research Inc
mi
from
Walnut creek, CA
Click here to add this to my saved trials
Accuracy Characterization Study
Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System Compared to Venous and Capillary Glucose
Status: Enrolling
Updated:  1/23/2017
Rainier Clinical Research Center
mi
from
Rainier, WA
Accuracy Characterization Study
Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System Compared to Venous and Capillary Glucose
Status: Enrolling
Updated: 1/23/2017
Rainier Clinical Research Center
mi
from
Rainier, WA
Click here to add this to my saved trials
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Status: Enrolling
Updated:  1/23/2017
Unger Primary Care Medical Center & Catalina Research Institute
mi
from
Chino, CA
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Status: Enrolling
Updated: 1/23/2017
Unger Primary Care Medical Center & Catalina Research Institute
mi
from
Chino, CA
Click here to add this to my saved trials
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Status: Enrolling
Updated:  1/23/2017
Dr. Deanna Cheung
mi
from
Long Beach, CA
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Status: Enrolling
Updated: 1/23/2017
Dr. Deanna Cheung
mi
from
Long Beach, CA
Click here to add this to my saved trials
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Status: Enrolling
Updated:  1/23/2017
University of California San Diego Veterns Affairs Medical Center
mi
from
San Diego, CA
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Status: Enrolling
Updated: 1/23/2017
University of California San Diego Veterns Affairs Medical Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Status: Enrolling
Updated:  1/23/2017
Henry Ford Medical Center
mi
from
Detroit, MI
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Status: Enrolling
Updated: 1/23/2017
Henry Ford Medical Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Status: Enrolling
Updated:  1/23/2017
St. Luke's Endocrinology and Diabetes
mi
from
Kansas City, MO
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Status: Enrolling
Updated: 1/23/2017
St. Luke's Endocrinology and Diabetes
mi
from
Kansas City, MO
Click here to add this to my saved trials
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Status: Enrolling
Updated:  1/23/2017
Duke Southern Regional AHEC
mi
from
Fayetteville, NC
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Status: Enrolling
Updated: 1/23/2017
Duke Southern Regional AHEC
mi
from
Fayetteville, NC
Click here to add this to my saved trials
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Status: Enrolling
Updated:  1/23/2017
Diabetes America- Pearland
mi
from
Pearland, TX
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
Status: Enrolling
Updated: 1/23/2017
Diabetes America- Pearland
mi
from
Pearland, TX
Click here to add this to my saved trials
Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study
Personalized Health Planning in Shared Medical Appointments for Individuals With Type II
Status: Enrolling
Updated:  1/23/2017
Duke Family Medicine Center
mi
from
Durham, NC
Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study
Personalized Health Planning in Shared Medical Appointments for Individuals With Type II
Status: Enrolling
Updated: 1/23/2017
Duke Family Medicine Center
mi
from
Durham, NC
Click here to add this to my saved trials
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Cypress, CA
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Cypress, CA
Click here to add this to my saved trials
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Los Angeles, CA
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Aurora, CO
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Iowa City, IA
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Iowa City, IA
Click here to add this to my saved trials
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Louisville, KY
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Kansas City, MO
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Cincinnati, OH
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Cleveland, OH
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Toledo, OH
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Toledo, OH
Click here to add this to my saved trials
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Philadelphia, PA
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Pittsburgh, PA
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Memphis, TN
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Dallas, TX
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Brussels,
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
Liraglutide: A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Pediatric (10-17 Years Old) With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Brussels,
Click here to add this to my saved trials
Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo
A Randomized Controlled Clinical Trial of Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo
Status: Enrolling
Updated:  1/25/2017
Parkland Memorial Hospital
mi
from
Dallas, TX
Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo
A Randomized Controlled Clinical Trial of Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo
Status: Enrolling
Updated: 1/25/2017
Parkland Memorial Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes
A Phase 1, Exploratory, Randomized, Double-Blind, Two-Way Cross Over Study to Assess Pharmacokinetic and Pharmacodynamic Effects of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  1/25/2017
Profil Institute for Clinical Research
mi
from
San Diego, CA
PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes
A Phase 1, Exploratory, Randomized, Double-Blind, Two-Way Cross Over Study to Assess Pharmacokinetic and Pharmacodynamic Effects of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 1/25/2017
Profil Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Examine Changes in GIP Plasma Levels Following Gastric Bypass Surgery in Obese Patients
A Pilot Study to Examine the Relationship Between Changes in Plasma GIP Levels and Other Gastrointestinal Peptides Following Gastric Bypass Surgery in Obese Patients
Status: Enrolling
Updated:  1/25/2017
Boston University Medical Center
mi
from
Boston, MA
A Study to Examine Changes in GIP Plasma Levels Following Gastric Bypass Surgery in Obese Patients
A Pilot Study to Examine the Relationship Between Changes in Plasma GIP Levels and Other Gastrointestinal Peptides Following Gastric Bypass Surgery in Obese Patients
Status: Enrolling
Updated: 1/25/2017
Boston University Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir
Insulin Detemir Co-administered With Liraglutide: An Open Label Trial to Assess Insulin Detemir and Liraglutide Pharmacokinetics and Pharmacodynamics Following Liraglutide Therapy in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Chula Vista, CA
Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir
Insulin Detemir Co-administered With Liraglutide: An Open Label Trial to Assess Insulin Detemir and Liraglutide Pharmacokinetics and Pharmacodynamics Following Liraglutide Therapy in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group
NNC 90-1170 Mechanism of Action: A Double-blind, Randomized, Single-center, Placebo Controlled, Crossover Study to Examine Beta-cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Ann Arbor, MI
Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group
NNC 90-1170 Mechanism of Action: A Double-blind, Randomized, Single-center, Placebo Controlled, Crossover Study to Examine Beta-cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
NNC 90-1170 Dose-response, Efficacy and Safety: A 12-week Randomized, Multicenter, Doubleblind, Double-dummy, Parallel-group Study of Metformin and Five Doses of NNC 90-1170 in Previously-treated OHA Monotherapy Obese Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Vestavia, AL
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
NNC 90-1170 Dose-response, Efficacy and Safety: A 12-week Randomized, Multicenter, Doubleblind, Double-dummy, Parallel-group Study of Metformin and Five Doses of NNC 90-1170 in Previously-treated OHA Monotherapy Obese Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Vestavia, AL
Click here to add this to my saved trials
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
NNC 90-1170 Dose-response, Efficacy and Safety: A 12-week Randomized, Multicenter, Doubleblind, Double-dummy, Parallel-group Study of Metformin and Five Doses of NNC 90-1170 in Previously-treated OHA Monotherapy Obese Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Tucson, AZ
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
NNC 90-1170 Dose-response, Efficacy and Safety: A 12-week Randomized, Multicenter, Doubleblind, Double-dummy, Parallel-group Study of Metformin and Five Doses of NNC 90-1170 in Previously-treated OHA Monotherapy Obese Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
NNC 90-1170 Dose-response, Efficacy and Safety: A 12-week Randomized, Multicenter, Doubleblind, Double-dummy, Parallel-group Study of Metformin and Five Doses of NNC 90-1170 in Previously-treated OHA Monotherapy Obese Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Carlisle, AR
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
NNC 90-1170 Dose-response, Efficacy and Safety: A 12-week Randomized, Multicenter, Doubleblind, Double-dummy, Parallel-group Study of Metformin and Five Doses of NNC 90-1170 in Previously-treated OHA Monotherapy Obese Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Carlisle, AR
Click here to add this to my saved trials
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
NNC 90-1170 Dose-response, Efficacy and Safety: A 12-week Randomized, Multicenter, Doubleblind, Double-dummy, Parallel-group Study of Metformin and Five Doses of NNC 90-1170 in Previously-treated OHA Monotherapy Obese Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Jonesboro, AR
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
NNC 90-1170 Dose-response, Efficacy and Safety: A 12-week Randomized, Multicenter, Doubleblind, Double-dummy, Parallel-group Study of Metformin and Five Doses of NNC 90-1170 in Previously-treated OHA Monotherapy Obese Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
NNC 90-1170 Dose-response, Efficacy and Safety: A 12-week Randomized, Multicenter, Doubleblind, Double-dummy, Parallel-group Study of Metformin and Five Doses of NNC 90-1170 in Previously-treated OHA Monotherapy Obese Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Alhambra, CA
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
NNC 90-1170 Dose-response, Efficacy and Safety: A 12-week Randomized, Multicenter, Doubleblind, Double-dummy, Parallel-group Study of Metformin and Five Doses of NNC 90-1170 in Previously-treated OHA Monotherapy Obese Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Alhambra, CA
Click here to add this to my saved trials
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
NNC 90-1170 Dose-response, Efficacy and Safety: A 12-week Randomized, Multicenter, Doubleblind, Double-dummy, Parallel-group Study of Metformin and Five Doses of NNC 90-1170 in Previously-treated OHA Monotherapy Obese Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/25/2017
Novo Nordisk Investigational Site
mi
from
Mission Viejo, CA
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
NNC 90-1170 Dose-response, Efficacy and Safety: A 12-week Randomized, Multicenter, Doubleblind, Double-dummy, Parallel-group Study of Metformin and Five Doses of NNC 90-1170 in Previously-treated OHA Monotherapy Obese Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/25/2017
Novo Nordisk Investigational Site
mi
from
Mission Viejo, CA
Click here to add this to my saved trials